Honeybee Metamorphosis: Genetic Switches Identified

Honeybee (Apis mellifera)
Photo Credit: Dmitry Grigoriev

Scientific Frontline: Extended "At a Glance" Summary: Honeybee Worker Metamorphosis Genetic Regulation

The Core Concept: Researchers have utilized Cap Analysis of Gene Expression (CAGE) technology to identify and map active "DNA switches"—known as enhancer sequences—that regulate the metamorphosis of Apis mellifera (honeybee) workers. This study provides the first empirical evidence of these regulatory sequences in action during the larval-to-adult transition.

Key Distinction/Mechanism: Unlike previous studies that relied on computational predictions of transcription factor binding sites from genome sequences, this approach identifies active enhancers by detecting enhancer RNA (eRNA) directly from worker honeybees. It establishes 15 specific transcription factor–enhancer–target gene relationships, including unique transcriptional regulation involving the tramtrack (ttk) gene that appears exclusive to the genus Apis.

Major Frameworks/Components:

• CAGE Technology: Used to quantify and locate active enhancer regions through bidirectional RNA transcription.
• Transcription Factors (TFs): Regulatory proteins including cycle, vismay, ttk, ovo, paired, GATAe, and daughterless that interact with enhancer sequences to drive gene expression.
• Metamorphic Regulators: The study specifically identified the activation of genes associated with Broad complex (Br-c) and E93.
• Evolutionary Divergence: The discovery of ttk-binding sequences that are highly conserved within Apis but absent in other bee lineages (e.g., bumblebees).

Biomolecular Chemistry: In-Depth Description

Biomolecular chemistry is the study of the chemical processes, structures, and interactions of the biological macromolecules that govern the complex functions of living organisms. The primary goal of this field is to elucidate how the molecular architecture of biological systems—such as proteins, nucleic acids, lipids, and carbohydrates—dictates their physiological behaviors, metabolic pathways, and cellular interactions at a fundamental, mechanistic level.

Silver Nanoparticles for Precise DNA Assembly

Image Credit: Scientific Frontline

Scientific Frontline: Extended "At a Glance" Summary: Silver Nanoparticles for DNA Cutting and Joining

The Core Concept: A novel genetic engineering technology utilizing silver nanoparticles to precisely cleave and assemble DNA at targeted sites, achieving two to five times higher efficiency than conventional methods.

Key Distinction/Mechanism: Traditional DNA assembly relies on restriction enzymes that cut at limited, specific sequences and produce short overhanging sequences ("sticky ends"). This new method uses chemical cleavage via polyethylene glycol (PEG)-coated silver nanoparticles targeting 3′-thiol-modified DNA. This allows for the generation of significantly longer sticky ends (up to 18 bases) and enables the physical removal of unwanted DNA fragments through centrifugation, resulting in a 98% DNA recovery rate.

Major Frameworks/Components: 

• Silver Nanoparticles: The primary chemical agents used to induce targeted DNA cleavage.
• Polyethylene Glycol (PEG) Coating: A water-soluble polymer applied to the nanoparticles to ensure chemical stability, dispersion, and high efficiency at ambient temperatures (50°C).
• 3′-Thiol-Modified DNA: The specific oligonucleotide modification targeted by the nanoparticles to initiate precise strand cleavage.
• Long Sticky Ends: Extended single-stranded DNA overhangs (8 to 18 bases long) created by the cleavage process, which drastically improve fragment binding.
• T4 DNA Ligase: The standard enzyme utilized to permanently join the newly generated, highly compatible DNA fragments.

Optimizing DNA Origami Nanostructures

Image Credit: Scientific Frontline / Stock Image

Scientific Frontline: Extended "At a Glance" Summary: DNA Origami Assembly Optimization

The Core Concept: Scaffolded DNA origami is a technique that utilizes a long scaffold strand and numerous short staple strands to self-assemble highly precise two- and three-dimensional nanoscale objects.

Key Distinction/Mechanism: Unlike traditional approaches reliant on generic scaffolds, a newly developed computational framework actively predicts and minimizes unwanted off-target sequence interactions, significantly improving structural folding yield and mechanical uniformity.

Major Frameworks/Components:

• Scaffold Strands: Long DNA or RNA sequences that serve as the structural foundation.
• Staple Strands: Shorter DNA strands that bind to specific regions of the scaffold upon thermal cycling, pulling it into the desired geometric shape.
• Sequence Selector Algorithm: A computational software tool designed to optimize staple sets by identifying favorable scaffold regions and mitigating non-specific interactions.
• Multi-Objective Computational Framework: A systematic approach to selecting sequences that minimize kinetic traps and assembly errors during the molecular folding process.

Branch of Science: Synthetic Biology, Nanotechnology, Biophysics, Computing Science.

Future Application: The synthesis of nano-vehicles for the targeted delivery of exogenous biomolecules (such as mRNA) to cells, along with scalable biosensors and agritech solutions.

Why It Matters: By overcoming the misfolding and kinetic traps that previously hindered the reliability of DNA origami, this optimization enables the robust and consistent fabrication of custom-designed nanoscale objects for clinical, agricultural, and commercial applications.

What Is: Extracellular Vesicles (Exosomes)

Scientific Frontline: Extended "At a Glance" Summary: Exosomes and Extracellular Vesicles

The Core Concept: Exosomes are highly specific, nanoscale extracellular vesicles (30 to 150 nm in diameter) that function as a biological "molecular internet," transporting targeted payloads of proteins, lipids, and nucleic acids (such as mRNA and miRNA) to facilitate complex, systemic intercellular communication.

Key Distinction/Mechanism: Unlike microvesicles that simply pinch off from a cell's outer surface, true exosomes are generated deep within the cell's internal endosomal system. They are formed as intraluminal vesicles (ILVs) inside multivesicular bodies (MVBs) and are actively secreted into the extracellular space only when the MVB fuses with the outer plasma membrane.

Origin/History: Exosomes were independently discovered in 1983 by two research teams studying reticulocyte maturation. For nearly two decades, the scientific community dismissed them as a cellular waste disposal mechanism. A paradigm shift occurred in the late 1990s and 2000s when researchers discovered their immune-stimulating properties and their ability to transfer functional genetic material between cells.

What Is: Ebola (Orthoebolavirus zairense)

Ebola virus (species Orthoebolavirus zairense).
Image Credit: CDC

Scientific Frontline: Extended "At a Glance" Summary: Orthoebolavirus zairense (Ebola Virus)

The Core Concept: Orthoebolavirus zairense is a highly sophisticated filovirus that relies on complex molecular evasion, the exploitation of immune-privileged sanctuaries, and the induction of societal disruption to ensure its survival and propagation, challenging its traditional, simplified classification as merely an agent of acute hemorrhagic fever.

Key Distinction/Mechanism: Unlike pathogens that trigger immediate immune clearance, this virus actively subverts the human immune system through RNA editing (overproducing the sGP protein to hijack antibody responses) and establishes long-term chronicity by physically breaking down cellular barriers to hide in the central nervous system, eyes, and testes.

Origin/History: The virus maintains a peaceful evolutionary truce within its natural chiropteran (bat) reservoir. Bats harbor the virus asymptomatically due to an evolutionary genomic mutation (S358) in their STING pathway, which dampens their inflammatory response to accommodate the severe metabolic demands of flight.

RELA Gene Boundary & Rare Inflammatory Disease

Scientists identified a key breakpoint in the RELA gene that helps predict how harmful mutations cause a rare inherited inflammatory disease. Mutations in a location before amino acid P290 reduce protein levels, while those located after P290 produce disruptive proteins. The finding could improve diagnosis and treatment selection for patients with RELA deficiency.
Image Credit: Hiroko Hayakawa/Hiroshima University

Scientific Frontline: Extended "At a Glance" Summary: The RELA Gene Boundary Discovery

The Core Concept: Researchers have identified a critical structural boundary within the immune-regulating gene RELA—specifically at amino acid proline 290 (P290)—that dictates how genetic mutations manifest in patients with a rare inherited inflammatory disease.

Key Distinction/Mechanism: Mutations occurring before the P290 boundary result in haploinsufficiency (a harmful shortage of functional protein). Conversely, mutations occurring after P290 cause a dominant-negative effect, where an abnormal, shortened protein actively interferes with normal cellular function and triggers more severe inflammation.

Major Frameworks/Components:

• Autosomal Dominant RELA Deficiency: A rare genetic condition characterized by recurrent ulcers, intestinal inflammation, and broader autoinflammatory symptoms.
• Haploinsufficiency vs. Dominant-Negative Effect: The two distinct pathological pathways determined by the genetic mutation's physical location relative to the P290 breakpoint.
• Stop Codons: Premature nucleotide sequences that terminate protein synthesis, driving the specific type of molecular failure depending on where they occur.

Synthetic Biology: In-Depth Description

Synthetic biology is a multidisciplinary area of research that involves the design and construction of novel biological parts, devices, and systems, as well as the re-design of existing, natural biological systems for useful purposes. Its primary goal is to apply rigorous engineering principles to biology, allowing scientists to program biological cells much like computers, thereby enabling organisms to produce new substances, respond to specific environmental cues, or perform entirely new functions that do not exist in nature.

Mini-Antibodies Reactivate the Guardian of the Genome

Structure of the DNA-binding domain of a reactivated p53 cancer mutant in complex with a stabilizing DARPin.
Image Credit: Andreas Joerger, Goethe University Frankfurt

Scientific Frontline: Extended "At a Glance" Summary: Mini-Antibodies Reactivating p53

The Core Concept: The p53 protein, widely known as the "guardian of the genome," is a crucial tumor suppressor that is mutated in approximately half of all cancer cases; researchers have engineered miniature antibodies called DARPins to stabilize these mutated proteins and restore their protective function.

Key Distinction/Mechanism: Unlike traditional small-molecule therapies that are constrained to targeting single, specific mutations, DARPins can selectively bind to and stabilize a vast array of different p53 mutants simultaneously. Furthermore, while conventional antibodies strictly target extracellular proteins, this new approach uniquely targets and operates on proteins inside the cell.

Origin/History: Developed by a scientific consortium comprising research groups from Goethe University Frankfurt, Philipps University Marburg, the University of Cologne, and the University of Zurich.

Scientists pave the way for fast, cost-effective custom enzyme development

The SMART single-molecule display model, predicted by Alphafold3, shows SpDAAO (red) linked to a puromycin linker (magenta) through puromycin incorporation into the growing polypeptide. The mRNA (gray) is hybridized and chemically joined to the linker, connecting it to its protein, SpDAAO. An auxiliary unit is added using ORC hairpin DNA (blue) with APEX2-scCro fusion protein (green).
Image Credit: Hideo Nakano and Jasmina Damnjanović

Scientific Frontline: Extended "At a Glance" Summary: SMART Method for Custom Enzyme Development

The Core Concept: SMART (Single-Molecule Assay on Ribonucleic acid by Translated product) is an advanced in vitro selection platform designed to accelerate directed enzyme evolution. It significantly reduces the time and cost required to identify superior enzyme variants by tracking them at the single-molecule level.

Key Distinction/Mechanism: Unlike traditional directed evolution, which often requires screening up to 100 trillion candidate variants over several weeks, the SMART system links an enzyme protein directly to its corresponding messenger RNA (mRNA) blueprint using puromycin as a chemical bridge. An auxiliary unit utilizing engineered ascorbate peroxidase 2 (APEX2) detects target enzyme activity by attaching a biotin marker to nearby molecules, allowing for rapid isolation and capture of the successful variants.

Origin/History: Developed by a collaborative research group led by Nagoya University, the Institute of Science Tokyo, and Saitama University, the SMART method builds upon the Nobel Prize-winning strategy of directed evolution. The findings, which demonstrate the system's ability to reduce screening time from weeks to just a few days without the need for specialized equipment, were published in ACS Synthetic Biology.

What Is: Connectomics

Scientific Frontline: Extended "At a Glance" Summary: Brain Wiring Explained

The Core Concept: Connectomics is the production, study, and comprehensive analysis of connectomes—the exquisitely detailed, complete wiring diagrams of an organism's nervous system. It represents a paradigm shift that models the brain not as a collection of isolated regions, but as a dense, dynamic, and interconnected network in order to uncover the physical substrate of consciousness, memory, and behavior.

Key Distinction/Mechanism: Unlike traditional neuroscience, which typically examines isolated cellular fragments or low-resolution functional regions, connectomics merges systems biology with big data and artificial intelligence. It cross-references static structural anatomy (the physical "wires") with functional connectivity (synchronized electrical activity) to trace precise neural circuitry and network communication patterns.

Origin/History: The field's foundation was laid in 1986 with the mapping of the Caenorhabditis elegans nematode (302 neurons). The connectome concept was globally popularized in 2010 by computational neuroscientist Sebastian Seung. The field recently achieved unprecedented scaling milestones, including the 2024 complete mapping of the adult fruit fly brain (over 50 million synaptic connections) by the FlyWire Consortium, and the 2026 "H01" petascale reconstruction of a cubic millimeter of the human temporal cortex by Harvard University and Google Research.

mRNA vaccines follow unconventional immune path to destroy tumors

WashU Medicine researchers have described how mRNA cancer vaccines engage the immune system, through an unconventional pathway involving two subsets of immune cells called dendritic cells.
Image Credit: Sara Moser/WashU Medicine

Scientific Frontline: Extended "At a Glance" Summary: mRNA Cancer Vaccine Immune Pathways

The Core Concept: Washington University researchers have discovered that mRNA cancer vaccines activate anti-tumor immune responses through an unconventional pathway utilizing two distinct subsets of dendritic cells. This challenges the previous assumption that only one specific immune cell subtype was required for these vaccines to effectively target and destroy tumors.

Key Distinction/Mechanism: Traditionally, cDC1 (classical type 1 dendritic cells) were thought to be the primary activators of T cells against viruses and tumors. However, this research demonstrates that a related subtype, cDC2, also independently stimulates strong T-cell responses. The cDC2 cells accomplish this through a "cross-dressing" mechanism, where they outsource the translation and processing of mRNA instructions to other cells, subsequently acquiring the resulting protein fragments on their own cellular membranes to engage T cells.

Major Frameworks/Components:

• Messenger RNA Biomolecules: Delivered instructions that prompt immune cells to synthesize specific tumor protein fragments.
• Dendritic Cell Subsets (cDC1 and cDC2): Antigen-presenting cells responsible for priming the immune system. Both subsets are now proven necessary for an optimal anti-tumor response.
• T-Cell Activation: The generation of specialized "seek and destroy" immune cells, which exhibit distinct molecular "fingerprints" depending on whether they were activated by cDC1 or cDC2 cells.
• Cellular "Cross-Dressing": An unconventional process where cDC2 cells acquire intact antigen-membrane complexes from adjacent cells rather than translating the mRNA themselves.

What Is: Epigenetics

Scientific Frontline: Extended "At a Glance" Summary: Epigenetics

The Core Concept: Epigenetics refers to the precise molecular mechanisms that dynamically alter gene expression and cellular differentiation without changing the underlying sequence of DNA nucleotides.

Key Distinction/Mechanism: While genetic mutations permanently alter the DNA sequence over successive generations, epigenetic modifications are rapid, highly dynamic, and fundamentally reversible. Operating as cellular "dimmer switches," epigenetic mechanisms manipulate transcription by either directly blocking access to the DNA or structurally remodeling the chromatin into open (euchromatin) or closed (heterochromatin) states in response to environmental factors, stressors, and developmental cues.

Origin/History: Historically, molecular biology was dominated by the unidirectional flow of the central dogma (DNA to RNA to protein) and strict genetic determinism. As the genomic era matured, it became clear that identical somatic cell genomes could not independently account for complex cellular differentiation or real-time environmental adaptability, leading to the discovery of the epigenome as the regulatory layer governing a "Reactive Genome."

Researchers find way to treat lung cancer and associated muscle wasting at the same time

Illustration shows depicts treating lung tumors with lipid nanoparticles loaded with follistatin.
Image Credit: Parinaz Ghanbari

Scientific Frontline: Extended "At a Glance" Summary: Dual-Targeted mRNA Therapy for Lung Cancer and Cachexia

The Core Concept: This novel therapeutic approach utilizes specialized lipid nanoparticles (LNPs) to deliver follistatin messenger RNA (mRNA) directly to lung tumors, simultaneously inhibiting cancer growth and reversing cachexia, a severe muscle-wasting syndrome.

Key Distinction/Mechanism: Unlike conventional LNPs, which typically accumulate in the liver following systemic administration, these modified LNPs bind to the blood serum protein vitronectin. The vitronectin directs the LNPs specifically to lung cancer tumors by interacting with integrin receptors that are overexpressed on the tumor surface. Once absorbed, the mRNA instructs the cells to produce follistatin, a protein known to suppress tumor progression and stimulate muscle tissue growth.

Major Frameworks/Components: 

• Lipid Nanoparticles (LNPs): Nanoscale delivery vehicles composed of fatty acids designed to carry genetic material intravenously without degrading.
• Follistatin mRNA: The therapeutic genetic payload that triggers the endogenous production of the dual-action follistatin protein.
• Vitronectin: A naturally occurring blood serum protein that binds to the LNPs and acts as a homing beacon.
• Integrin Receptors: Surface receptors overexpressed on lung cancer cells that interact with vitronectin to facilitate the precise cellular uptake of the LNPs.

CryoPRISM: A new tool for observing cellular machinery in a more natural environment

In unfavorable conditions, ribosomes, the molecular machinery that creates proteins, are made idle by hibernation factors that help ribosomes avoid reactivation, like a sleeping mask that prevents a person from being woken up by light. Using a new method called cryoPRISM, researchers found that some ribosomes interacted not only with a hibernation factor, but also with another factor, previously believed in bacteria to only interact with active ribosomes.
Image Credit: Ekaterina Khalizeva

Scientific Frontline: Extended "At a Glance" Summary: CryoPRISM

The Core Concept: CryoPRISM (purification-free ribosome imaging from subcellular mixtures) is an advanced structural biology imaging technique that enables researchers to observe biomolecular complexes, such as ribosomes, within their near-natural cellular environments.

Key Distinction/Mechanism: Unlike traditional methodologies that require isolating and extensively purifying molecules—which risks altering their natural structures—cryoPRISM captures high-resolution molecular states using unpurified cellular lysates from freshly burst cells. This approach preserves native molecular interactions and cellular context without the immense technical and resource demands of full in-cell imaging.

Origin/History: Developed by graduate students Mira May and Gabriela López-Pérez in the Davis Lab at the MIT Department of Biology. The technique originated from an unexpected discovery when a negative control experiment utilizing unpurified bacterial lysate yielded intact, naturally interacting ribosomes rather than the anticipated noisy, low-quality data.

What Is: Cellular Senescence

In the center, a single senescent "zombie" cell appears aged, enlarged, and distressed. It is actively emitting a glowing, noxious-looking mist or aura (representing the toxic SASP inflammatory factors). Surrounding it are healthy, vibrant, translucent cells
Image Credit: Scientific Frontline

Scientific Frontline: Extended "At a Glance" Summary: Cellular Senescence

The Core Concept: Cellular senescence is a biological paradigm in which a unique subpopulation of cells permanently and irreversibly stops dividing but evades apoptosis (programmed cell death). Instead of dying off, these arrested "zombie cells" remain metabolically hyperactive and linger within mammalian tissues.

Key Distinction/Mechanism: Senescence is distinct from quiescence, which is a temporary, reversible resting state in the G0 phase of the cell cycle. Senescence strictly locks cells in a permanent arrest during the G1 or G2 phases. Rather than clearing out, these cells secrete a complex, toxic cascade of inflammatory factors known as the Senescence-Associated Secretory Phenotype (SASP), which actively drives systemic tissue degradation and remodels the local cellular microenvironment.

Origin/History: The phenomenon was first documented in 1961 by researchers Leonard Hayflick and Paul Moorhead. They discovered that cultured primary human fibroblasts possess a strictly finite replicative lifespan, establishing a biological boundary now universally canonized as the Hayflick limit.

How faulty mRNA is destroyed

Image Credit: Scientific Frontline

Scientific Frontline: Extended "At a Glance" Summary: Nonsense-Mediated mRNA Decay (NMD)

The Core Concept: Nonsense-mediated mRNA decay (NMD) is an essential cellular quality-control process that inspects messenger RNA (mRNA) for errors and selectively degrades faulty or incomplete transcripts to prevent the synthesis of defective proteins.

Key Distinction/Mechanism: Unlike permanently active enzymes that could cause collateral damage to healthy mRNA, the NMD system relies on a precise safety mechanism. The proteins SMG5 and SMG6 have little to no cutting activity individually; however, when they interact, they form a highly active endonuclease—a molecular "pair of scissors"—that targets and cleaves flawed RNA with strict spatial and temporal precision.

Origin/History: While the individual proteins involved in this mechanism have been recognized for approximately 20 years, the exact nature of their interaction was recently solved by a collaborative research team from the University of Cologne and the Max Planck Institute of Biochemistry.

Major Frameworks/Components: 

• Messenger RNA (mRNA): The genetic blueprint copied from DNA, which dictates protein production.
• Nonsense-Mediated mRNA Decay (NMD): The overarching surveillance pathway that identifies transcript errors.
• SMG5 and SMG6 Proteins: The specific molecular components that interact to execute the destruction of faulty mRNA.
• Endonuclease Activity: The enzymatic cutting process resulting from the composite formation of the SMG5-SMG6 PIN domain.

Synthetic gene medicines may disrupt DNA repair

Marianne Farnebo | Linn Hjelmgren
Photo Credits
Ulf Sirborn | Sandro Schmidli

Scientific Frontline: Extended "At a Glance" Summary: Antisense Oligonucleotides (ASOs) and DNA Repair Disruption

The Core Concept: Antisense oligonucleotides (ASOs) are short, synthetic nucleic acid molecules utilized in gene therapies to regulate gene expression. Recent research indicates that these synthetic medicines can inadvertently disrupt the cellular systems responsible for detecting and repairing DNA damage.

Key Distinction/Mechanism: While natural DNA repair mechanisms activate in response to genuine structural damage, ASO molecules can bind directly to critical DNA repair enzymes and accumulate in dense nuclear clusters known as condensates or “PS bodies.” This binding falsely triggers a cellular repair signal even when no DNA damage exists, which can disrupt natural repair pathways and lead to an unsafe buildup of DNA alterations.

Major Frameworks/Components: 

• Antisense Oligonucleotides (ASOs): Synthetic nucleic acid sequences formulated to target, bind to, and regulate specific messenger RNA (mRNA) or gene expressions.
• Nuclear Condensates ("PS bodies"): Dense, abnormal clusters formed within the cell nucleus when ASOs interact with DNA repair proteins.
• False DNA Damage Response: The incorrect cellular activation of repair signaling mechanisms in the absence of actual DNA degradation.
• Endogenous RNA Dynamics: Studying synthetic ASO behavior provides parallel insights into how natural RNA counterparts function within native DNA repair systems.

Nanoparticle-based gene editing could expand treatment options for cystic fibrosis

Artistic rendering of gene editing reagents — mRNA (red) and DNA (green and yellow) constructs — being packaged into a lipid nanoparticle (blue).
Illustration Credit: Adalia Zhou

Scientific Frontline: "At a Glance" Summary

• Main Discovery: Lipid nanoparticles successfully delivered a full-length, healthy CFTR gene into human airway cells, restoring essential biological function in a cystic fibrosis model without the use of viral vectors.
• Methodology: Researchers engineered lipid nanoparticles to simultaneously transport three components—CRISPR/Cas9 machinery, guide RNA, and a full CFTR DNA template—and tested the system on lab-cultured human airway cells containing severe mutations.
• Key Data: While the gene was successfully integrated into only 3–4% of the target cells, the treated cell population demonstrated a restoration of 88–100% of normal CFTR channel function.
• Significance: By inserting a complete functional gene rather than fixing specific errors, this approach offers a potential universal, one-time treatment for all 1,700+ known cystic fibrosis mutations, particularly for the 10% of patients unresponsive to current drug therapies.
• Future Application: This modular, non-viral platform effectively solves the "big gene" delivery problem and could be adapted to treat other genetic lung diseases or conditions involving large genes that exceed the capacity of viral vectors.
• Branch of Science: Nanomedicine, Gene Therapy, and Pulmonary Medicine
• Additional Detail: The replacement gene underwent codon optimization to maximize protein production, enabling a small percentage of corrected cells to functionally compensate for the entire population.

Epigenetics: In-Depth Description

Epigenetics is the study of heritable changes in gene expression or cellular phenotype that do not involve alterations in the underlying DNA sequence. 

While primarily an interdisciplinary field that synthesizes the mechanics of biochemistry with the inheritance laws of genetics, Epigenetics also functions within a multidisciplinary framework in its broader applications. It serves as the bridge between the stable "hardware" of the genome and the dynamic signals of the environment. The primary goal of this field is to understand the mechanisms that determine when and where specific genes are turned "on" or "off," thereby dictating cell identity, function, and response to environmental stimuli.